Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multicenter, Extension Study for Patients Previously Enrolled in Studies With Pelabresib

NCT06401356 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT06401356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06401356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multicenter, Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Lead sponsor
Novartis Pharmaceuticals
Phase
Phase 3
Overall status
Recruiting
Start date
August 13, 2024
Completion date
June 30, 2027
Enrollment
50 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignancies, hematologic malignancy, solid tumor